An increasing number of women with permeal and after menopause are looking for “biofeen” hormones as an alternative to hormone replacement treatments approved by the FDA. Unfortunately, the use of hormonal therapy for menopause symptoms is surrounded by myths and misconceptions. At a time characterized by the growing distrust of the healthcare system and the pharmaceutical industry, many people turn to the internet for information instead of consulting healthcare providers. This online landscape, often dominated by convincing advertising, promotes false allegations and excessive promises. As a result, consumers can give up effective treatments or unknowingly choose treatments that are unproven and potentially harmful. Thus, it is important to prioritize research based on evidence to ensure safe and effective care.
What are the biodegradant hormones?
- True or false: Biomedical hormones are identical to the hormones naturally produced by the body.
True. The term “Bioidian” refers to hormones that are chemical and structurally identical to those produced by the human body. - True or False: All biofuel hormones are approved by the FDA.
False. While some biochentic hormones, such as estradiol and micronium progesterone, are approved by the FDA, complex biomedical hormone therapies are not regulated by the FDA.
Safety and efficiency
- True or False: Complex biofuel hormones are safer than FDA -approved hormone treatments.
False. There is no scientific evidence to argue that complex biodegrade hormones are safer or more effective than FDA -approved treatments. In fact, complex compositions may bear additional risks, such as inconsistent dosage, infection and lack of supervision. - True or false: Complex biochentic hormone therapy has been severely testing in clinical trials.
False. Complex bio -hormone treatments have not been evaluated in randomized test tests, making their effectiveness and safety uncertain. - True or False: FDA -approved biochentic hormones bear less risks than traditional hormone treatments.
False. Biomedical hormones approved by the traditional hormone replacement therapy, including increased risk of blood clots, stroke, breast cancer and endometrial cancer.
Allegations and misunderstandings
- True or false: hormone tests are essential for the guidance of dosage for biochentic hormone treatment.
False. The FDA recommends that it does not use hormone levels to guide the dosage because hormone levels naturally range and the trials of salivary are unreliable. - True or false: Biomedical hormones can help maintain youth and promote weight loss.
False. The claims that biomedical hormones can maintain youth or help weight loss are unfounded and are often used as regular marketing and not as evidence -based recommendations.
Adjustment and supervision
- True or False: Complex biofuel hormones are subject to the same regulatory standards as FDA -approved drugs.
False. Complex biofuel hormones do not have FDA supervision, which means that their purity, power and safety are not guaranteed. - True or False: Pharmacies that complex biofeen hormones should report adverse reactions to the FDA.
False. Unlike FDA -approved drug manufacturers, the pharmacies they combine do not need to report adverse reactions to the FDA.
Clinical recommendations
- True or False: Professional Organizations are a complex biotemic hormone treatment for menopausal symptoms.
False. Organizations such as North America Menopause are warning against the use of complex biodic hormones due to inadequate evidence that supports their safety and efficiency. - True or False: Hormones are more effective than non -hormonal therapies for managing menopause symptoms.
False. While biodegradable hormones can be effective for some women, non -hormonal therapies, such as selective serotonin reuptake inhibitors (SSRIs), serotonin reuptake inhibitors, mood disorders and sleep disorders. Non -hormonal choices are particularly valuable for women who cannot or do not prefer to use hormonal therapies.
The bottom line
Biomedical hormone treatment is often misunderstood due to marketing claims and misinformation about its safety and efficacy compared to traditional hormone replacement therapy. While the FDA -approved biomedical hormones can be a viable option for some women, the worsening versions do not have strict tests and regulation, posing potential risks to be carefully examined with a healthcare provider167.
Ruta Nonacs, MD PhD
References
Kauffman RP, MacLaughlin EJ, Courtney La, Vineyard Dd. Fear, misinformation and pharmaceutical messianism in promoting complex bioidal hormone therapy. Front health. 2024 Feb 29; 6: 1378644.
